Molecule Details
| InChIKey | CLPFFLWZZBQMAO-CQSZACIVSA-N |
|---|---|
| Compound Name | 4-[(5r)-5,6,7,8-Tetrahydroimidazo[1,5-A]pyridin-5-Yl]benzonitrile |
| Canonical SMILES | N#Cc1ccc([C@H]2CCCc3cncn32)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.16 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB21746 |
|---|---|
| Drug Name | Dexfadrostat |
| CAS Number | 102676-87-9 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Dexfadrostat is under investigation in clinical trial NCT04007406 (DP13 - a Phase II Study in Patients With Primary Aldosteronism). |
Cross-references: BindingDB: 50047262 CHEMBL287677 PDB: 0T3 ZINC: ZINC000001851916
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P15538 | CYP11B1 | Cytochrome P450 11B1, mitochondrial | inhibitor | targets |